| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 239.260 | 191.437 | 173.663 | 250.526 | 270.524 | 191.548 | 104.771 | 403.960 | 193.806 | 191.957 |
| Total Income - EUR | 239.763 | 193.273 | 194.218 | 250.564 | 270.532 | 198.450 | 107.909 | 406.121 | 201.850 | 206.410 |
| Total Expenses - EUR | 206.572 | 171.845 | 169.173 | 228.934 | 240.563 | 191.162 | 104.551 | 308.097 | 179.412 | 155.759 |
| Gross Profit/Loss - EUR | 33.191 | 21.428 | 25.044 | 21.630 | 29.969 | 7.288 | 3.358 | 98.024 | 22.439 | 50.651 |
| Net Profit/Loss - EUR | 27.612 | 18.000 | 22.847 | 19.125 | 27.264 | 5.317 | 2.279 | 94.100 | 20.420 | 45.486 |
| Employees | 2 | 2 | 3 | 4 | 4 | 2 | 2 | 3 | 4 | 2 |
Check the financial reports for the company - Trans Orvirel Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 262.198 | 281.007 | 338.286 | 298.423 | 314.454 | 291.808 | 369.075 | 398.680 | 426.862 | 436.886 |
| Current Assets | 164.531 | 144.019 | 127.856 | 185.776 | 200.781 | 171.315 | 103.721 | 148.572 | 112.943 | 119.345 |
| Inventories | 28.840 | 40.048 | 35.416 | 43.011 | 38.074 | 40.528 | 40.251 | 15.989 | 33.686 | 16.470 |
| Receivables | 54.582 | 48.602 | 74.810 | 61.808 | 66.164 | 40.086 | 48.876 | 72.438 | 52.101 | 47.854 |
| Cash | 81.109 | 55.368 | 17.629 | 80.958 | 96.544 | 90.702 | 14.594 | 60.145 | 27.156 | 55.022 |
| Shareholders Funds | 282.710 | 297.827 | 315.634 | 316.574 | 306.785 | 306.286 | 269.428 | 364.364 | 383.679 | 427.021 |
| Social Capital | 4.162 | 4.120 | 4.050 | 3.976 | 3.899 | 3.825 | 3.740 | 3.751 | 3.740 | 3.719 |
| Debts | 178.991 | 161.815 | 184.537 | 202.217 | 241.435 | 191.243 | 203.537 | 182.888 | 156.126 | 129.211 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
812
|
|||||||||
Comments - Trans Orvirel Srl